Glenn W. Welling - Engaged Capital 13F Activity & Position Changes (Q4 2024)

According to the SEC 13F filed on Feb 14, 2025, the Engaged Capital portfolio showed several notable changes in holdings as of quarter-end Dec 31, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2024, the filing reported:

New Buys - Chart Industries, Inc.

Increases - Evolent Health, Inc

Reductions - NCR Atleos Corporation, PRA Group, Inc., NCR Voyix Corporation

Complete Exits - BlackLine, Inc., Nevro Corp.

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q4 2024	BL BlackLine, Inc.	BlackLine, Inc.	Sell - Position Exit	-609,713	-100.0%	$0.00	-
Q4 2024	EVH Evolent Health, Inc	Evolent Health, Inc	Buy	+1,415,300	+35.5%	$60.80M	5,404,768
Q4 2024	GTLS Chart Industries, Inc.	Chart Industries, Inc.	Buy - Position Entry	+224,796	-	$42.90M	224,796
Q4 2024	NATL NCR Atleos Corporation	NCR Atleos Corporation	Sell	-802,182	-26.7%	$74.83M	2,206,041
Q4 2024	NVRO Nevro Corp.	Nevro Corp.	Sell - Position Exit	-2,442,956	-100.0%	$0.00	-
Q4 2024	PRAA PRA Group, Inc.	PRA Group, Inc.	Sell	-1,083,567	-63.6%	$12.95M	619,945
Q4 2024	VYX NCR Voyix Corporation	NCR Voyix Corporation	Sell	-1,399,996	-19.5%	$79.87M	5,771,033